The NCRI Head and Neck Group’s “Hypopharynx cancer trials” Working Group sets out to achieve Priority 3 of the NCRI Head and Neck Group Strategic Priorities: To improve outcomes for patients with locally advanced hypopharyngeal cancer.

This priority aims to improve outcomes for locally advanced hypopharyngeal cancer patients by designing a study that will deliver direct patient benefit to a patient population with current unmet need.

You can see the full list of strategic priorities for the NCRI Head and Neck Group here.